Pharmaceutical Translation With Regulatory Terminology Accuracy.

Pharmaceutical translation mistakes have real consequences -- a mistranslated dosing instruction on a package insert, an incorrectly rendered contraindication in a regulatory submission, or an inaccurate adverse event description in a pharmacovigilance report. The accuracy standard in pharmaceutical documentation is higher than general technical translation because errors reach patients through prescribers, pharmacists, and package labeling.

We assign pharmaceutical translators with verifiable background in pharmacology, pharmacy, or pharmaceutical regulatory affairs. They understand the regulatory context they are translating within -- whether that is FDA labeling requirements, EMA SmPC format conventions, or ICH E6(R2) Good Clinical Practice guidelines for trial documentation.

Common pharmaceutical translation requests include: Summary of Product Characteristics (SmPC); Patient Information Leaflets (PIL); Investigator's Brochures; Clinical Study Reports; Pharmacovigilance reports and individual case safety reports (ICSRs); EU and US regulatory submission modules; manufacturing batch records; quality management documentation; and CMC (Chemistry, Manufacturing, and Controls) sections.

For clients submitting to multiple regulatory jurisdictions simultaneously, we can coordinate parallel translation workflows across target markets to maintain consistency in terminology and submission timing.